galactose

Identity evidence

Record which observations distinguish galactose from plausible accompanying or substituted sugars.

1. Which reference-supported structural or analytical evidence identifies this material as galactose? definition
2. Does the method resolve glucose and other plausible hexose interferents in this matrix? measurement

Configuration assignment

Record D/L assignment separately from alpha/beta assignment and retain uncertainty where evidence is absent.

1. What evidence establishes D, L or mixed galactose rather than leaving configuration unresolved? provenance
2. Does each linked identifier describe galactose generally or a particular configuration and ring form? boundary

Preparation basis

Connect weighed or dispensed material to its actual galactose content.

1. Is the material solid, fully dissolved or partially dissolved, and in which solvent at what temperature? measurement
2. What assay and water-content corrections are needed to prepare the requested galactose concentration? action

Form observation conditions

Keep anomeric or ring assignments tied to solvent, temperature and elapsed time after preparation.

1. Which anomeric and ring forms were measured, by what method and how long after dissolution? measurement
2. Must the preparation reach a documented stable form distribution before the intended measurement or reaction? action

Free versus released basis

Record whether the result concerns native free galactose or a protocol-defined released amount.

1. Does this result measure free galactose before hydrolysis, galactose after hydrolysis or the corrected difference? definition
2. Which intact parent compounds are linked as possible contributors without being identified as free galactose? boundary

Matrix and recovery

Record calibration, recovery and reporting basis for the actual sample matrix.

1. What galactose value, units, wet or dry basis, uncertainty and quantification limit are reported? measurement
2. What controls establish recovery and exclude sugar interference or preparation-induced loss in this matrix? measurement

Purity and co-components

Distinguish galactose assay from other sugars, water and impurities relevant to the intended use.

1. What measured fractions of galactose, other sugars and water support the declared purity? measurement
2. Which lot-specific certificate or analytical record supports those values and their reporting basis? provenance

Retest triggers

Record storage or preparation events that make the previous galactose assay insufficient.

1. What evidence shows whether storage, heating or solution handling changed galactose content or impurity composition? measurement
2. Which documented condition or elapsed interval requires reassay before this galactose preparation is used? action

Application fit

Record the requirements for use as a reference, reagent, ingredient or biological substrate.

1. What configuration, assay, impurity and preparation requirements does the named use impose? boundary
2. Does the available evidence support using this material, or must it be held for further measurement? action

Galactose input and output

Link galactose quantities and resulting substances to a separately modelled reaction or biological system.

1. Which linked process consumes or releases galactose, and what measured change establishes that relationship? measurement
2. At what transformation does the tracked material require identification as a neighbouring compound rather than galactose? boundary

Kinds and varieties

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• D-galactose (the biologically prevalent enantiomer; C4-epimer of D-glucose)
• L-galactose (the rare enantiomer; occurs in some plant and algal polysaccharides)
• α-D-galactopyranose and β-D-galactopyranose (anomeric ring forms in solution and in glycosides)
• open-chain (aldehyde) D-galactose, in equilibrium with the cyclic forms
• galactose 1-phosphate and UDP-galactose (Leloir-pathway intermediates)
• N-acetyl-D-galactosamine (GalNAc; a common glycosylation residue, distinct from free galactose)
• galactitol (dulcitol; the reduction product accumulated in galactosemia)

1. Which of these kinds and varieties hold for the sense of galactose this model covers, and on what evidence? provenance

Identifiers and schemes

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• Wikidata - Q399553 (galactose); Q123280 (D-galactose) - Parent vs D-enantiomer items; confirm before linking a registry row.
• CAS Registry Number - 59-23-4 (D-galactose); 26566-61-0 (unspecified/DL galactose); 15572-79-9 (L-galactose) - Use the enantiomer-specific CAS for chemical identity; 59-23-4 is the usual biochemical reagent.
• PubChem CID - 6036 (D-galactose) - NCBI PubChem compound record.
• ChEBI - CHEBI:28061 (D-galactose); CHEBI:28260 (galactose)
• InChIKey - GZCGUPFRVQAUEE-KCDKBNATSA-N (open-chain D-galactose); the pyranose anomers have distinct keys
• IUPAC name - (2R,3S,4S,5R)-2,3,4,5,6-pentahydroxyhexanal (open-chain D-galactose)
• EC number (enzyme, not the sugar) - EC 2.7.1.6 (galactokinase); EC 2.7.7.12 (UDP-glucose - hexose-1-phosphate uridylyltransferase, GALT); EC 5.1.3.2 (UDP-glucose 4-epimerase, GALE) - Leloir-pathway enzymes that define metabolic identity of galactose, not identifiers of the molecule itself.
• HS / customs - 2940.00 (sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose - check chapter notes) or 1702 as other sugars, depending on purity and intended use - Classification is product-form dependent; do not treat a single HS code as canonical.

1. Which of these identifiers and schemes hold for the sense of galactose this model covers, and on what evidence? provenance

Standards and regulation

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• IUPAC Nomenclature of Carbohydrates (Recommendations 1996) / IUPAC Gold Book - configurational (D/L) and ring (pyranose/furanose, α/β) naming of galactose.
• Codex Alimentarius CXS 212-1999 (Standard for Sugars) and Codex dairy standards - galactose as a constituent of lactose and as a food sugar; labelling of lactose-containing foods.
• EU Regulation (EU) No 1169/2011 on food information to consumers - lactose as an allergen/intolerance substance; galactose itself is not a listed allergen but is the relevant residue in lactose.
• FDA 21 CFR (food additive / GRAS and nutrition labelling) - D-galactose used as a nutrient and in infant-formula carbohydrate declarations; lactose labelling.
• CLSI / AACC clinical laboratory methods and national newborn-screening programmes (e.g. US Recommended Uniform Screening Panel) - blood-spot total galactose and GALT enzyme assay for galactosemia.
• WHO / ICD coding of galactosemia (classic galactosemia, GALT deficiency) as a treatable inborn error requiring dietary galactose restriction.

1. Which of these standards and regulation hold for the sense of galactose this model covers, and on what evidence? provenance

Real-world use

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• Dietary: released by intestinal lactase from milk lactose (glucose + galactose); present in dairy, some fermented products, and as free sugar in small amounts in legumes and some fruits.
• Metabolism: converted in liver and other tissues via the Leloir pathway (GALK → GALT → GALE) to UDP-glucose for glycogen and glycoprotein synthesis.
• Glycobiology: β-D-galactopyranosyl residues in glycolipids (e.g. galactocerebroside of myelin), N- and O-glycans, and the ABO/Lewis blood-group oligosaccharides.
• Clinical: substrate of newborn screening and of the galactose elimination-capacity (GEC) liver-function test; restricted in galactosemia diets (and secondarily limited in severe lactose intolerance).
• Industrial / reagent: D-galactose as a biochemical reagent, cell-culture carbon source (e.g. yeast GAL promoters), and precursor for galactitol, mucic acid, and some pharma intermediates.
• Materials: monomer of agarose/agar (with 3,6-anhydro-L-galactose) and of plant galactans and pectins (galacturonic acid is the oxidized analogue).

1. Which of these real-world use hold for the sense of galactose this model covers, and on what evidence? provenance

Typical measurements

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• molecular formula / molar mass - C6H12O6; 180.16 - g·mol⁻¹
• specific optical rotation [α]D (D-galactose, equilibrium in water) - approximately +80 (mutarotation from α ~+150 toward the equilibrium mixture) - degrees (c in water, sodium D line)
• melting point (anhydrous D-galactose) - about 165-170 (anomer- and hydrate-dependent) - °C
• aqueous solubility (20-25 °C) - high; on the order of 600-700 g per litre (very soluble) - g·L⁻¹
• blood / plasma free galactose (healthy fasting adult) - typically <0.2-0.5 (often reported as <1) - mmol·L⁻¹ (or mg·dL⁻¹; 1 mmol·L⁻¹ ≈ 18 mg·dL⁻¹)
• newborn-screen total galactose (dried blood spot cutoff, programme-specific) - action cutoffs commonly around 1-2 mmol·L⁻¹ equivalent, with GALT enzyme as the companion test - mmol·L⁻¹ (whole-blood equivalent)
• erythrocyte galactose-1-phosphate (classic galactosemia on diet) - treatment target often <3-4; untreated neonates much higher - mg·dL⁻¹ packed red cells (lab-method dependent)

1. Which of these typical measurements hold for the sense of galactose this model covers, and on what evidence? provenance

Failure modes and hazards

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• Classic galactosemia (biallelic GALT deficiency): neonatal liver failure, E. coli sepsis, cataract from galactitol in the lens, ovarian failure and long-term neurocognitive impairment even on diet.
• Galactokinase (GALK) deficiency: mainly cataracts from galactitol; Duarte and other hypomorphic GALT variants cause milder biochemical elevations.
• UDP-galactose 4-epimerase (GALE) deficiency: spectrum from benign red-cell enzyme loss to severe, multi-organ disease.
• Dietary lactose/galactose in an undiagnosed neonate: acute hepatic and renal toxicity; milk feeding is the usual precipitant.
• Analytical confusion of total reducing sugars or of glucose assays that cross-react, leading to missed or false-positive galactosemia screens.
• Iatrogenic: galactose load in the GEC liver test is contraindicated or hazardous in galactosemia; high-dose galactose is not a general toxin in galactosemia-unaffected people at food levels.
• Occupational/chemical: crystalline sugar dust is a combustible-dust and housekeeping hazard in bulk handling, not a specific toxicology of galactose.

1. Which of these failure modes and hazards hold for the sense of galactose this model covers, and on what evidence? provenance

Regional variation

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• Newborn-screening panels and cutoffs for total galactose / GALT activity differ by country and even by US state; some programmes screen GALT enzyme only.
• Dietary galactose restriction practice (strict lactose-free vs measured liberalisation after infancy) varies among metabolic clinics in Europe, North America, and Japan.
• Food naming: 'galactose' as a listed ingredient is uncommon; it is usually implicit in lactose, hydrolysed lactose ('glucose-galactose syrup'), or 'milk sugar'. Some jurisdictions require lactose declaration above a threshold; others do not list free galactose.
• Plant vs dairy sources: in East Asian diets with low dairy intake, dietary galactose is dominated by legumes, fermented soy, and plant galactans rather than milk lactose.

1. Which of these regional variation hold for the sense of galactose this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

• D-glucose - C4 epimers (glucose has C4-OH equatorial in the ⁴C₁ pyranose; galactose has C4-OH axial). Separate by specific optical rotation, HPLC/HPAEC retention, enzymatic assays (galactose oxidase or galactose dehydrogenase vs glucose oxidase/hexokinase), and NMR of H4.
• lactose (4-O-β-D-galactopyranosyl-D-glucose) - Disaccharide that yields galactose + glucose on hydrolysis (lactase or acid). TLC/HPLC of intact lactose vs monosaccharides; lactase digestion followed by galactose-specific assay.
• D-fructose - Ketose vs aldose; Seliwanoff test, enzymatic fructose assay, and distinct HPLC retention. Not an epimer of galactose.
• D-mannose - C2 epimer of glucose, not of galactose. Chromatographic and enzymatic distinction (mannose isomerase / hexokinase specificity); NMR of H2.
• galacturonic acid - C6-oxidized analogue (pectin monomer). Acidic on ion-exchange; distinct CAS/ChEBI; does not substitute for galactose in Leloir metabolism.
• N-acetyl-D-galactosamine (GalNAc) - 2-acetamido-2-deoxy derivative common in mucins and blood-group A. Hexosamine-specific assays and mass (m/z) separate it from hexose galactose.
• galactitol (dulcitol) - Sugar alcohol from aldose reductase acting on galactose; no reducing aldehyde. Polyol chromatography (GC of acetates) and absence of reducing-sugar tests.

1. Which of these neighbouring kinds and how to tell them apart hold for the sense of galactose this model covers, and on what evidence? provenance